1103 related articles for article (PubMed ID: 27193196)
1. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
Zhang H; Bennett JL; Verkman AS
Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
[TBL] [Abstract][Full Text] [Related]
4. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
Yao X; Verkman AS
Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
[TBL] [Abstract][Full Text] [Related]
5. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
7. The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.
Geis C; Ritter C; Ruschil C; Weishaupt A; Grünewald B; Stoll G; Holmoy T; Misu T; Fujihara K; Hemmer B; Stadelmann C; Bennett JL; Sommer C; Toyka KV
Exp Neurol; 2015 Mar; 265():8-21. PubMed ID: 25542977
[TBL] [Abstract][Full Text] [Related]
8. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
9. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
10. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Asavapanumas N; Verkman AS
Acta Neuropathol Commun; 2014 Apr; 2():48. PubMed ID: 24758159
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
13. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
Tradtrantip L; Felix CM; Spirig R; Morelli AB; Verkman AS
Neuropharmacology; 2018 May; 133():345-353. PubMed ID: 29428821
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
15. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
[TBL] [Abstract][Full Text] [Related]
16. [Pathology of neuromyelitis optica].
Misu T
Rinsho Shinkeigaku; 2009 Nov; 49(11):896-9. PubMed ID: 20030242
[TBL] [Abstract][Full Text] [Related]
17. Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica.
Duan T; Smith AJ; Verkman AS
J Neuroinflammation; 2018 Oct; 15(1):294. PubMed ID: 30348195
[TBL] [Abstract][Full Text] [Related]
18. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
Lucchinetti CF; Guo Y; Popescu BF; Fujihara K; Itoyama Y; Misu T
Brain Pathol; 2014 Jan; 24(1):83-97. PubMed ID: 24345222
[TBL] [Abstract][Full Text] [Related]
19. Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.
Yao X; Verkman AS
Acta Neuropathol Commun; 2017 Jul; 5(1):57. PubMed ID: 28750658
[TBL] [Abstract][Full Text] [Related]
20. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
